🔎 Trials Near Me

Akèy › Kansè (tout kalite) › Texas › Tyler

Etid klinik pou Kansè (tout kalite) nan Tyler, TX

7 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Tyler (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

Ap rekriteFaz 3
  • Texas Oncology - Northeast Texas, Tyler
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07566156

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Ap rekriteFaz 3
  • Texas Oncology - Northeast Texas /ID# 280642, Tyler
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07365241

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1
  • University of Texas at Tyler, Tyler
Laj 18 a 99 · Tout sèks · Mizajou Sep 1, 2026 · NCT06983743

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Ap rekriteFaz 1/2
  • The University of Texas Health Science Center at Tyler, Tyler
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT04198766

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Ap rekriteFaz 1
  • Texas Oncology - Northeast Texas /ID# 268877, Tyler
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05650632

A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)

Ap rekriteFaz 1
  • GSK Investigational Site, Tyler
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT06551142

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

Ap rekriteFaz 2
  • Texas Oncology - Tyler, Tyler
Laj 18 ak plis · Tout sèks · Mizajou Nov 13, 2025 · NCT05997017

Etid Kansè (tout kalite) nan lòt vil

Lòt etid nan Tyler

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.